Article info
PDFShort report
Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer
- Correspondence to Professor Giancarlo Troncone, Public Health, University of Naples Federico II, Naples 80131, Italy; giancarlo.troncone{at}unina.it
Citation
Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer
Publication history
- Received January 13, 2021
- Revised February 8, 2021
- Accepted February 9, 2021
- First published March 1, 2021.
Online issue publication
May 15, 2022
Article Versions
- Previous version (20 April 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.